Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia
暂无分享,去创建一个
J. Iliff | N. Sugo | N. Alkayed | D. Koop | Jeffrey J. Iliff | A. DeBarber | Takashi Otsuka | Yazan Alhadid | Wenri Zhang | A. Ardeshiri | Wenri H. Zhang | Wenri H Zhang | Andrea DeBarber
[1] R. Noppens,et al. Soluble Epoxide Hydrolase: A Novel Therapeutic Target in Stroke , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] B. Hammock,et al. Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted Mice* , 2007, Journal of Biological Chemistry.
[3] N. Alkayed,et al. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[4] J. Falck,et al. Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function , 2006, Circulation research.
[5] D. Grant,et al. Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis. , 2006, Biochemical and biophysical research communications.
[6] R. Koehler,et al. Role of astrocytes in cerebrovascular regulation. , 2006, Journal of applied physiology.
[7] B. Hammock,et al. Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase. , 2005, Biochemistry.
[8] N. Alkayed,et al. Hypoxic Preconditioning and Tolerance via Hypoxia Inducible Factor (HIF) 1α-linked Induction of P450 2C11 Epoxygenase in Astrocytes , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] J. Liao,et al. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. , 2005, Archives of biochemistry and biophysics.
[10] B. Hammock,et al. Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. , 2005, Annual review of pharmacology and toxicology.
[11] J. Mitchell,et al. Not so EEZE: the 'EDHF' antagonist 14, 15 epoxyeicosa-5(Z)-enoic acid has vasodilator properties in mesenteric arteries. , 2004, European journal of pharmacology.
[12] N. Alkayed,et al. Cytochrome P450 in neurological disease. , 2004, Current drug metabolism.
[13] M. Barbe,et al. Determination of bioactive eicosanoids in brain tissue by a sensitive reversed-phase liquid chromatographic method with fluorescence detection. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[14] W. Campbell,et al. Membrane Potential-Dependent Inhibition of Platelet Adhesion to Endothelial Cells by Epoxyeicosatrienoic Acids , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[15] R. DuBois,et al. Targeted lipidomics using electron capture atmospheric pressure chemical ionization mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.
[16] J. Falck,et al. 14,15-Epoxyeicosa-5(Z)-Enoic-mSI: A 14,15- and 5,6-EET Antagonist in Bovine Coronary Arteries , 2003, Hypertension.
[17] B. Hammock,et al. The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Traystman,et al. Neuroprotection and P450 2C11 Upregulation After Experimental Transient Ischemic Attack , 2002, Stroke.
[19] R. Traystman,et al. Estrogen and Bcl-2: Gene Induction and Effect of Transgene in Experimental Stroke , 2001, The Journal of Neuroscience.
[20] Jian-Kang Chen,et al. Cytochrome P450 Epoxygenase Metabolism of Arachidonic Acid Inhibits Apoptosis , 2001, Molecular and Cellular Biology.
[21] F. Gonzalez,et al. Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation* , 2000, The Journal of Biological Chemistry.
[22] M. Kluger,et al. Role of cytochrome P-450 in endogenous antipyresis. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[23] K. Ley,et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. , 1999, Science.
[24] B. Hammock,et al. Soluble epoxide hydrolase in rat inflammatory cells is indistinguishable from soluble epoxide hydrolase in rat liver. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[25] H. Ellis. stroke , 1997, The Lancet.
[26] A. Hudetz,et al. Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. , 1996, The American journal of physiology.
[27] R. Roman,et al. Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. , 1996, Stroke.
[28] B. Hammock,et al. Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice. , 1995, Biochemical pharmacology.
[29] E. Ellis,et al. Metabolism of Arachidonic Acid to Epoxyeicosatrienoic Acids. Hydroxyeicosatetraenoic Acids, and Prostaglandins in Cultured Rat Hippocampal Astrocytes , 1993, Journal of neurochemistry.
[30] J. Krieglstein,et al. Pharmacology of cerebral ischemia : proceedings of the International Symposium on Pharmacology of Cerebral Ischemia, held in Marburg (FRG) on 16-17 July 1986 , 1986 .